At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia.
about
Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidityEtiology of cardiovascular disease in patients with schizophrenia: current perspectivesObesity and psychotic disorders: uncovering common mechanisms through metabolomicsPharmacogenomics in type 2 diabetes: oral antidiabetic drugs.The ventral habenulae of zebrafish develop in prosomere 2 dependent on Tcf7l2 function.Using genetic, cognitive and multi-modal neuroimaging data to identify ultra-high-risk and first-episode psychosis at the individual level.TCF7L2 polymorphisms and the risk of schizophrenia in the Chinese Han populationBayesian semiparametric copula estimation with application to psychiatric geneticsModulation ofTcf7l2 expression alters behavior in mice.Association of the type 2 diabetes mellitus susceptibility gene, TCF7L2, with schizophrenia in an Arab-Israeli family sampleTranslational neuroscience of schizophrenia: seeking a meeting of minds between mouse and man.An in vivo cis-regulatory screen at the type 2 diabetes associated TCF7L2 locus identifies multiple tissue-specific enhancers.Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors.Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits.Novel β-catenin target genes identified in thalamic neurons encode modulators of neuronal excitability.Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden.Wnt signaling and the control of human stem cell fate.Microarray Analysis of Human Blood During Electroconvulsive Therapy.Clinicians' adherence to clinical practice guidelines for cardiac function monitoring during antipsychotic treatment: a retrospective report on 434 patients with severe mental illness.Cell type-specific binding patterns reveal that TCF7L2 can be tethered to the genome by association with GATA3.Interventions for the metabolic syndrome in schizophrenia: a reviewPolygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives.The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review.Metabolic syndrome in schizophrenia: theoretical, clinical and translational perspectives.Postnatal isoform switch and protein localization of LEF1 and TCF7L2 transcription factors in cortical, thalamic, and mesencephalic regions of the adult mouse brain.Preliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder.Metabolic profile at first-time schizophrenia diagnosis: a population-based cross-sectional study.TNiK is required for postsynaptic and nuclear signaling pathways and cognitive functionTCF4 (e2-2; ITF2): a schizophrenia-associated gene with pleiotropic effects on human disease.Physiological role of β-catenin/TCF signaling in neurons of the adult brain.Running for your life: A review of physical activity and cardiovascular disease risk reduction in individuals with schizophrenia.Diabetes and Schizophrenia.Screening of cardiovascular risk factors in patients with schizophrenia and patients treated with antipsychotic drugs: are we equally exhaustive as with the general population?In vitro scan for enhancers at the TCF7L2 locus.Psychiatric disorders and obesity: A review of association studiesGenetic Background Limits Generalizability of Genotype-Phenotype Relationships.Diabetes, physical activity participation and exercise capacity in patients with schizophrenia.Genetic association study between the detected risk variants based upon type II diabetes GWAS and psychotic disorders in the Japanese population.A polygenic score for schizophrenia predicts glycemic control.Accumulating evidence for a role of TCF7L2 variants in bipolar disorder with elevated body mass index.
P2860
Q26752342-8A3DA169-68CA-430F-A210-343D4359F042Q26778485-D7D6A371-390E-4BDB-B72A-3E9E64F3E5C8Q27011617-419597DD-EE83-4BB5-9434-2850B0521C45Q30248914-4ECBE917-F61F-4F1C-8026-092748A0EA71Q30557277-649F063C-F77B-4EB1-92C2-CE634AAAAF05Q30603105-CB9DF6B5-9C6D-43FD-BE46-91AD9D5741EAQ33709807-2F8EBE26-A52F-4C27-B87E-89D7DBCF8225Q33867602-B865DF03-C5E7-46D6-B0CE-94014C2722BBQ34064796-D2EC6EBB-F0BB-4D45-845B-E67C946A3E0CQ34128452-3CC92C6A-433D-4F4A-88CD-D6E66F0722DFQ34220141-AC152347-42C1-4621-9BF7-63EB2CD38076Q34270782-4BC25F52-D063-426E-BF32-0C43A2DAB7FCQ34325802-9D01518D-9F25-408E-BA06-3223D32F68FEQ34379379-587D0496-EDAE-45D8-A778-90A74D6C00CAQ34479682-69549814-2E8A-420F-AEA7-FB61DBC1015EQ34571634-FB922B42-4161-49B7-9DCA-C36949D744B9Q34658275-08ACFFEF-4F32-4BA1-9778-E0C6EACA1360Q36298817-A75E2CDA-AC5D-4C51-9358-04F7E1ACD5A2Q36328767-0D75DE29-874B-4E9B-9119-F55B534C67A6Q36378040-1922B43B-39DB-476A-9B2F-581AA355FFEFQ36401248-DDE8A6F8-50F3-4B39-B273-804198F95E39Q36784390-9E222E3A-429C-43E4-86FA-313B2288E7A0Q37079080-2B98DFBE-2576-44EB-B50A-F89EB1B2C104Q37176819-8C161D17-6F43-4118-94EE-88F8C669CA1DQ37301034-16B33D97-0578-43F5-AD37-07A48E320DC2Q37642812-A5A4D9CF-39ED-4C8D-B8E0-543FE16D90D8Q37682840-34DECADA-DA20-4532-8BB8-406D209EBB8BQ37690413-5F6EE4D5-A8FC-42E4-A843-07D5A74EACA3Q38057999-291E4C14-1080-48BE-B2B1-0F31B72D049DQ38078834-F19EFAE5-F125-4454-8589-779B30A9B3C1Q38656912-F8CF1600-5ABF-4A9C-8475-806C58810654Q38709352-0CB9CB87-B5D2-4EE9-8165-1B4E2BE4843BQ38738796-99813241-9ADA-4506-A4B5-478191309B44Q39271500-7D7A75CE-AD97-40D9-B9DE-4F3AA2BE89A7Q39427970-501DD9C2-E013-4341-B4E9-18EE984A36A0Q41159260-5E7DAE89-4454-4618-9D4F-C5BE106259F2Q46197558-26D5316A-74BA-4C4E-B9FB-799D37BA17C8Q46884539-E3D1104B-5DE7-45D4-89E1-0E65E370C537Q47294911-0D75D2E7-C080-459D-9F67-ECDF3FD37A02Q47629882-818AED92-8CDB-4538-B35D-EF88A8ECFF97
P2860
At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia.
@en
At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia.
@nl
type
label
At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia.
@en
At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia.
@nl
prefLabel
At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia.
@en
At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia.
@nl
P2093
P50
P1476
At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia.
@en
P2093
Andrés Ingason
Chiara Bonetto
David A Collier
David St Clair
Hannes Pétursson
Henrik B Rasmussen
Josef Frank
Klaus D Jakobsen
Leena Peltonen
P356
10.1016/J.BIOPSYCH.2011.01.031
P407
P50
P577
2011-03-16T00:00:00Z